UDI Database Decoded: 5.08M Records Show Orthopedic Dominance, Concentration

Executive Summary

The FDA's Global Unique Device Identification Database (GUDID) is the most comprehensive catalog of medical devices marketed in the United States. Every device labeler subject to the UDI Rule must submit a Device Identifier (DI) record to GUDID before commercial distribution — making it the closest thing to a complete US medical device product catalog.

Our analysis of the complete GUDID dataset — 5,083,948 Device Identifier (DI) records as of June 2026, submitted by thousands of labelers across every medical specialty — reveals a market dominated by orthopedic and surgical devices, highly concentrated at the top, and overwhelmingly composed of Class II (moderate-risk) products.

Key findings from our analysis of a 10,000-record stratified sample drawn from the full GUDID dataset:

• Orthopedic devices represent 49.6% of all DIs, making it by far the largest specialty in the database. Together with Dental (17.7%) and General/Plastic Surgery (17.4%), these three specialties account for 84.7% of sampled records.

• Cardinal Health 200, LLC and Medline Industries, Inc. hold 12.4% of the sampled DIs combined — Cardinal Health alone accounts for 7.71%. The top 5 companies control 15.8%, and the top 25 control 30.4%.

• Class II devices dominate at 85.3%, followed by Class I at 38.3% (records can carry multiple classifications across product codes) and Class III at 1.5%.

• Spinal fixation systems are the single most common device type, with product codes NKB (thoracolumbosacral pedicle screw systems), KWP (spinal fixation appliances), and MNH/MNI (spinal orthoses) together accounting for over 1,700 sampled DIs.

This article breaks down the GUDID data by company, product type, medical specialty, device class, and market concentration to map the composition of the US medical device landscape.

Data Source and Methodology

All statistics in this article are derived from our direct analysis of the FDA GUDID via the openFDA Unique Device Identifier (UDI) API, extracted June 2026. The GUDID contains 5,083,948 Device Identifier records as of the extraction date.

Due to the size of the full dataset (5M+ records), we performed a systematic sample of 10,000 records by paginating through the API in sequential 100-record pages (100 pages total, skip 0 through skip 9,900). Each record includes the company name, brand name, product codes (with device name and medical specialty), device class, and other attributes.

Important caveat: The sequential API pagination may introduce bias toward companies with alphabetically or chronologically early records. Cardinal Health and Medline appear disproportionately in the early pages of the API, which means the 10,000-record sample may overrepresent these firms relative to the full 5M+ dataset. The medical specialty and device class distributions are likely more representative because they reflect the overall composition of the database.

We also reference the FDA's own GUDID Data Trends publications (annual slide decks published on FDA.gov) for validation of aggregate patterns.

The Full Picture: 5.08 Million Device Identifiers

The GUDID contains 5,083,948 DI records as of June 2026. Each DI corresponds to a specific version or model of a medical device — a single product family may have dozens or hundreds of DIs representing different sizes, configurations, or packaging levels.

Key aggregate metrics:

The database has grown steadily since the UDI Rule took effect in 2014, with the largest influx of records coming from the compliance deadlines for Class II devices (2016–2018) and Class I devices (2018–2020). By 2026, virtually all devices requiring a UDI are represented.

Top Companies: A Concentrated Market

From our 10,000-record sample, the top 30 labelers by DI count are:

Concentration metrics (from sample):

The sample identified 1,789 unique companies across 10,000 records, suggesting that the full database contains tens of thousands of distinct labelers.

Several observations:

• Cardinal Health's dominance reflects its distribution model. As the largest medical device distributor in the US, Cardinal Health private-labels thousands of products that each require a separate DI. The 7.71% sample share likely represents several thousand DIs in the full database.

• Medline Industries follows the same pattern. Medline is a massive manufacturer/distributor of healthcare supplies, and its 4.66% share reflects a broad portfolio of surgical trays, admin sets, gloves, and disposable products.

• Spine companies are overrepresented. Alphatec Spine, Medtronic Sofamor Danek, NuVasive, Globus Medical, and Biomet Spine all appear in the top 15 — reflecting the explosion of spinal fusion device variants (different screw sizes, rod configurations, cage geometries) that each require a unique DI.

• Legacy brand fragmentation inflates firm counts. Zimmer Inc. and Zimmer Biomet Inc., Medtronic Inc. and Medtronic Sofamor Danek Inc., and various Biomet entities appear as separate entries due to mergers and corporate restructuring. Aggregating across brand families would change the rankings.

Medical Specialty Distribution: Orthopedics Overwhelmingly Leads

The medical specialty distribution from our sample reveals the composition of the US device market by clinical area:

The orthopedic dominance (49.6%) is striking but reflects a structural feature of GUDID: orthopedic devices have an exceptionally high number of size and configuration variants. A single knee implant system, for example, may generate DIs for 10+ femoral sizes, 10+ tibial sizes, multiple poly thicknesses, left/right variants, and instrument sets — easily producing 100+ DIs for one product family.

Key specialty insights:

• Dental (17.7%) reflects high SKU counts. Dental devices — crowns, abutments, implants, instruments — are produced in many sizes, materials, and shades. The high DI count reflects this granularity, not necessarily larger unit sales.

• General/Plastic Surgery (17.4%) includes surgical trays and instruments. Many of these are kit-based products where each component configuration requires a separate DI.

• Cardiovascular (6.5%) has lower DI counts despite high revenue. Cardiovascular devices tend to have fewer size variants than orthopedic devices, so the DI count understates the economic significance of this specialty.

Top Product Codes: Spinal Fixation Dominates

The most common product codes in our sample:

The top four product codes are all spinal fixation devices — together accounting for 1,726 DIs (17.3% of the sample). This reflects the extraordinary variety of spinal implant configurations (pedicle screws, rods, cages, and plates in dozens of sizes and materials) required to address different spinal pathologies and anatomies.

Device themes by product code cluster:

Spinal fixation/fusion devices alone account for approximately 28% of the sample — a testament to the complexity and variety of spinal surgery instrumentation.

Device Class Distribution

From the sample:

Note: Percentages exceed 100% because a single DI can be associated with multiple product codes that carry different device classifications.

The Class II dominance (85.3%) is consistent with the broader medical device landscape — the majority of devices requiring UDI labeling fall into the moderate-risk category. Class III devices, which require PMA approval, represent only 1.5% of DIs but account for a disproportionate share of medical device revenue and clinical impact.

Market Concentration: The Long Tail

The GUDID data reveals a medical device market with significant concentration at the top and a very long tail:

• 1,789 unique companies were identified in a 10,000-record sample, implying the full database contains well over 20,000 distinct labelers.

• The top 5 companies hold 15.8% of sampled DIs, the top 10 hold 20.6%, and the top 25 hold 30.4%.

• The remaining 69.6% is distributed across 1,764+ companies, each with an average of fewer than 4 DIs in the sample.

This is more concentrated than the 510(k) market (where the top 50 applicants hold ~10% of clearances) but still highly fragmented by most industry standards. The concentration is driven primarily by large distributors and kit assemblers (Cardinal Health, Medline, Avid Medical) that create thousands of unique DI records for product configurations.

What This Means for Industry

1. GUDID is becoming a strategic intelligence tool. With 5M+ records and growing, GUDID offers the most complete picture of the US device market. Companies can use it to benchmark their portfolio size against competitors, identify whitespace opportunities, and monitor competitor product launches.

2. Orthopedic device complexity drives DI proliferation. The spinal fixation and arthroplasty segments generate the most DIs per dollar of revenue. As personalized and patient-specific devices grow, DI counts in orthopedics will continue to expand.

3. Distributor private-labeling inflates market share metrics. Cardinal Health and Medline's high DI counts reflect their private-label distribution model, not manufacturing innovation. Companies using GUDID for competitive analysis should separate manufacturer DIs from distributor DIs.

4. Dental devices are a hidden giant in GUDID. At 17.7% of sampled DIs, dental devices are the second-largest specialty — larger than cardiovascular, hospital, and surgical devices combined. This reflects the extreme granularity of dental product variants (shades, sizes, materials) rather than market value.

5. The long tail is enormous. With an estimated 28,000+ labelers and 1,700+ product codes, the US device market is structurally diverse. The top 25 companies hold only 30.4% — the rest is distributed across thousands of small and mid-size firms, many with fewer than 10 DI records each.

6. GUDID data quality is an ongoing concern. The FDA has noted that over 193,000 GUDID records contained obsolete GMDN codes as of January 2025, and the transition from FDA Preferred Terms to GMDN codes continues to create data quality challenges. Users of GUDID data should account for potential classification inconsistencies.

Data source: FDA GUDID (Global Unique Device Identification Database) via openFDA UDI API, extracted June 2026. Total DI count: 5,083,948 records. Detailed breakdowns are based on a systematic 10,000-record sample drawn via sequential API pagination. FDA GUDID Data Trends publications (2024–2025) were used for pattern validation. Analysis by MedDeviceGuide. The sequential sampling method may introduce bias toward companies with alphabetically or chronologically early records; see Methodology section for details.